HAEMONETICS CORP - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-12-01

Reporting Person: GRANADILLO PEDRO P (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-01	Common Stock	S	100	$57.225	Disposed	31663	Direct
2017-12-01	Common Stock	S	18	$57.18	Disposed	31763	Direct
2017-12-01	Common Stock	S	200	$57.17	Disposed	31781	Direct
2017-12-01	Common Stock	S	100	$57.15	Disposed	31981	Direct
2017-12-01	Common Stock	S	100	$57.14	Disposed	32081	Direct
2017-12-01	Common Stock	S	100	$57.13	Disposed	32181	Direct
2017-12-01	Common Stock	S	100	$57.125	Disposed	32281	Direct
2017-12-01	Common Stock	M	7118	$34.405	Acquired	38781	Direct
2017-12-01	Common Stock	S	300	$57.00	Disposed	38481	Direct
2017-12-01	Common Stock	S	100	$57.005	Disposed	38381	Direct
2017-12-01	Common Stock	S	100	$57.007	Disposed	38281	Direct
2017-12-01	Common Stock	S	100	$57.015	Disposed	38181	Direct
2017-12-01	Common Stock	S	91	$57.02	Disposed	38090	Direct
2017-12-01	Common Stock	S	100	$57.03	Disposed	37990	Direct
2017-12-01	Common Stock	S	9	$57.05	Disposed	37981	Direct
2017-12-01	Common Stock	S	4100	$57.055	Disposed	33881	Direct
2017-12-01	Common Stock	S	200	$57.06	Disposed	33681	Direct
2017-12-01	Common Stock	S	760	$57.07	Disposed	32921	Direct
2017-12-01	Common Stock	S	100	$57.0749	Disposed	32821	Direct
2017-12-01	Common Stock	S	200	$57.08	Disposed	32621	Direct
2017-12-01	Common Stock	S	200	$57.09	Disposed	32421	Direct
2017-12-01	Common Stock	S	40	$57.10	Disposed	32381	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-01	Non-qualified Stock Option (Right to Buy)	$34.405	M	7118	Disposed	2018-07-21	Common Stock (7118)	Direct

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.